Shoval Engineering and Construction Ltd (TLV:SHVL)

Intra-Cellular Therapies Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	14.62	14.6	103.05	45.57
Depreciation & Amortization	2.78	2.59	1.77	1.49
Loss (Gain) From Sale of Assets	-0.01	-0.01	-	-0.11
Asset Writedown & Restructuring Costs	-5.41	-5.41	-29.4	-13.29
Loss (Gain) From Sale of Investments	-	-	-47.41	-
Other Operating Activities	34.81	30.45	68.45	-34.05
Change in Accounts Receivable	-11.18	10.48	-104.59	158.53
Change in Inventory	36.18	10.71	-115.11	-133.38
Change in Unearned Revenue	88.29	88.29	-109.5	142.83
Operating Cash Flow	150.56	151.7	-232.75	167.6
Capital Expenditures	-7.15	-6.29	-3.63	-2.34
Sale of Property, Plant & Equipment	0.01	0.01	-	0.63
Cash Acquisitions	-	-	-	-11.08
Sale (Purchase) of Real Estate	-49.38	-54.09	-55.28	-30.28
Investment in Securities	-19.79	-5.78	27	-
Other Investing Activities	-58.46	-99.71	59.1	-96.52
Investing Cash Flow	-141.26	-170.41	24.72	-143.98
Short-Term Debt Issued	-	146.52	112.93	210.06
Long-Term Debt Issued	-	146.7	117.2	-
Total Debt Issued	376.47	293.22	230.13	210.06
Short-Term Debt Repaid	-	-217.79	-23.37	-196.62
Long-Term Debt Repaid	-	-6	-1.28	-0.98
Total Debt Repaid	-289.35	-223.79	-24.65	-197.6
Net Debt Issued (Repaid)	87.12	69.43	205.49	12.46
Common Dividends Paid	-11.45	-11.74	-8.15	-20.12
Other Financing Activities	-33.94	-33.27	-12.36	-5.01
Financing Cash Flow	113.07	24.42	184.98	-12.66
Net Cash Flow	122.38	5.71	-23.05	10.96
Free Cash Flow	143.41	145.41	-236.38	165.26
Free Cash Flow Margin	33.08%	32.77%	-71.63%	78.44%
Free Cash Flow Per Share	70.58	692.41	-1125.62	786.94
Cash Interest Paid	33.94	33.27	12.36	5.01
Cash Income Tax Paid	-	0.52	12.37	25.7
Levered Free Cash Flow	-	144.1	-	-
Unlevered Free Cash Flow	-	162.29	-	-
Change in Net Working Capital	-	-143.01	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.